Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
31 studies found for:    "atypical hemolytic-uremic syndrome" OR "Hemolytic-Uremic Syndrome"
Show Display Options
RSS Create an RSS feed from your search for:
"atypical hemolytic-uremic syndrome" OR "Hemolytic-Uremic Syndrome"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
An Open-label, Multi-center Clinical Trial of Eculizumab in Adult Patients With Atypical Hemolytic-uremic Syndrome
Condition: Atypical Hemolytic-Uremic Syndrome
Intervention: Drug: Eculizumab
2 Completed
Has Results
An Open-Label, Multi-Center Clinical Trial of Eculizumab in Pediatric Patients With Atypical Hemolytic-Uremic Syndrome
Condition: Atypical Hemolytic-Uremic Syndrome
Intervention: Drug: Eculizumab
3 Completed
Has Results
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: eculizumab
4 Unknown  Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease
Condition: Atypical Hemolytic Uraemic Syndrome.
Intervention:
5 Not yet recruiting Study of ALXN1210 in Children and Adolescents With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Intervention: Biological: ALXN1210
6 Recruiting Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry
Condition: Atypical Hemolytic-Uremic Syndrome
Intervention:
7 Completed A Retrospective, Observational, Non-interventional Trial to Assess Eculizumab Treatment Effect in Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Intervention:
8 Recruiting Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: eculizumab
9 Terminated aHUS Observational Long Term Follow-Up
Condition: Atypical Hemolytic Uremic Syndrome
Intervention:
10 Terminated Complement Inhibition in aHUS Dialysis Patients
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: CCX168
11 Completed
Has Results
Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-Resistant aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: Eculizumab
12 Completed
Has Results
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: Eculizumab
13 Completed
Has Results
Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Sensitive aHUS
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Drug: eculizumab
14 Completed The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Intervention: Drug: Eculizumab
15 Recruiting Single Arm Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)
Condition: Atypical Hemolytic Uremic Syndrome (aHUS)
Intervention: Biological: ALXN1210
16 Completed To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients
Condition: ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)
Intervention:
17 Enrolling by invitation Eval. of Potential Predictors of Disease Progression in Patients With aHUS Including Genetics, Biomarkers and Treatment
Condition: Atypical Hemolytic Uremic Syndrome
Intervention: Other: Clinical assessments and laboratory tests.
18 Completed Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4
Conditions: Hemolytic-uremic Syndrome;   Escherichia Coli Infections
Intervention: Other: HUS standard coverage care (including in ICU)
19 Completed Phase III Randomized Study of SYNSORB Pk in Children With E. Coli-Associated Hemolytic Uremic Syndrome
Condition: Hemolytic Uremic Syndrome
Intervention: Drug: SYNSORB Pk
20 Recruiting Study of 'Vascular Competence' Profile and Endothelial Activation in the Hemolytic Uremic Syndrome in Children and Adults
Condition: Hemolytic Uremic Syndrome
Intervention: Biological: Extra blood draw samples

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.